Department of Health and Ageing and MSAC logos
image of a microscope

Application 1041

Intravascular brachytherapy

Application No.

1041

Application NameIntravascular brachytherapy
Advisory PanelDr Michael Kitchener
(Chair and MSAC member)
Dr Tony Knittel
(Australasian College of Physical Scientists and Engineers in Medicine nominee)
Dr Leo Mahar
(co-opted member)
Dr Mark Pitney
(Cardiac Society of Australia and New Zealand nominee)
Dr George Quong
(Royal Australian and New Zealand College of Radiologists nominee)
Mr Ivan Kaye
(Consumers' Health Forum of Australia nominee)
Date Received by MSAC Secretariat1 March 2001
Stage 1 - EligibilityEligible
Stage 2 - AssessmentCompleted
Stage 3 - Formulation of Advice to the MinisterThis assessment was considered by the MSAC at the 21 August 2002 meeting.

The MSAC recommends that on the strength of evidence pertaining to intravascular brachytherapy for the treatment of coronary artery restenosis, interim public funding should be supported. This recommendation is to be reviewed no later than three years from the date of this report to ascertain whether longer term safety, effectiveness and cost-effectiveness has been proven and to determine the place of evolving technologies such as drug-coated stents in the treatment of in-stent restenosis.
Stage 4 - DecisionEndorsed by the Minister for Health and Ageing 16 October 2002
Stage 5 - Implementation